← Open Payments lookup

JESSICA HARKEY: Open Payments

NPI 1295377968 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,871 in 109 payments from 14 companies in 2025. Trend: 2023 $1,554 · 2024 $2,079 · 2025 $1,871

Food & beverage: $1,871
CompanyPaymentsAmount
Janssen Biotech, Inc.15$281
ABBVIE INC.22$261
Takeda Pharmaceuticals U.S.A., Inc.11$213
Aimmune Therapeutics, Inc.12$211
Madrigal Pharmaceuticals7$180
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$163
Celltrion USA Inc.11$153
QOL Medical, LLC6$151
GENZYME CORPORATION7$137
Phathom Pharmaceuticals, Inc.2$37

Products named: TREMFYA, ENTYVIO, RINVOQ, REZDIFFRA, XIFAXAN, DUPIXENT, VEGZELMA, Sucraid.

Industry payments across MS — which companies pay providers there.